|
11.
|
Exotic decay of $^{115}$Cs
/ Das, P (Saha Inst. ; HBNI, Mumbai) ; Datta, Ushasi (Saha Inst. ; HBNI, Mumbai) ; Chakraborty, S (Saha Inst. ; Pailan Coll. Mgt. Tech.) ; Rahaman, A (Saha Inst. ; A.C. Coll., Jalpaiguri) ; Tengblad, O (Madrid, Inst. Estructura Materia) ; Agrawal, B K (Saha Inst. ; HBNI, Mumbai) ; Becerril, A (Madrid, Inst. Estructura Materia) ; Cederkall, J (Lund U. (main)) ; Dey, J (Saha Inst. ; HBNI, Mumbai) ; Gottberg, A (CERN ; TRIUMF) et al.
The detailed study of the β+/EC decay of the very neutron-deficient and alpha-unbound nucleus Cs115 is presented. The measurement was performed at the ISOLDE, CERN where delayed charged particles and γ rays were detected. [...]
2023 - 6 p.
- Published in : Phys. Rev. C 108 (2023) 064304
Fulltext: PDF;
|
|
|
12.
|
|
|
13.
|
Axial and triaxial degrees of freedom in $^{72}$Zn
/ Hellgartner, S (Munich, Tech. U.) ; Mücher, D (Cologne U. ; Guelph U. ; TRIUMF) ; Wimmer, K (Darmstadt, GSI ; Madrid, Inst. Estructura Materia ; Tokyo U.) ; Bildstein, V (Guelph U.) ; Egido, J L (Madrid, Autonoma U.) ; Gernhäuser, R (Munich, Tech. U.) ; Krücken, R (LBNL, NSD) ; Nowak, A K (Munich, Tech. U.) ; Zielinska, M (IRFU, Saclay) ; Bauer, C (Darmstadt, Tech. U.) et al.
The unstable N=42 nucleus 72Zn has been studied using multiple safe Coulomb excitation in inverse kinematics. The experiment was performed at the REX-ISOLDE facility at CERN making first use of the silicon detector array C-REX in combination with the γ-ray spectrometer Miniball. [...]
2023 - 8 p.
- Published in : Phys. Lett. B 841 (2023) 137933
Fulltext: PDF;
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
/ Vermeulen, Koen (SCK-CEN, Mol) ; Van de Voorde, Michiel (SCK-CEN, Mol) ; Segers, Charlotte (SCK-CEN, Mol) ; Coolkens, Amelie (SCK-CEN, Mol) ; Pérez, Sunay Rodriguez (SCK-CEN, Mol) ; Daems, Noami (SCK-CEN, Mol) ; Duchemin, Charlotte (Leuven U. ; CERN) ; Crabbé, Melissa (SCK-CEN, Mol) ; Opsomer, Tomas (SCK-CEN, Mol) ; Vargas, Clarita Saldarriaga (SCK-CEN, Mol) et al.
Samarium-153 is a promising theranostic radionuclide, but low molar activities (Am) resulting from its current production route render it unsuitable for targeted radionuclide therapy (TRNT). Recent efforts combining neutron activation of $^{152}$Sm in the SCK CEN BR2 reactor with mass separation at CERN/MEDICIS yielded high-Am $^{153}$Sm. [...]
2022 - 15 p.
- Published in : Pharmaceutics 14 (2022) 2566
Fulltext: PDF;
|
|
|
17.
|
|
|
18.
|
Resonant laser ionization and mass separation of $^{225}$Ac
/ Johnson, Jake D (Leuven U.) ; Heines, Michael (Leuven U.) ; Bruchertseifer, Frank (Geel, JRC) ; Chevallay, Eric (CERN) ; Cocolios, Thomas E (Leuven U.) ; Dockx, Kristof (Leuven U.) ; Duchemin, Charlotte (Leuven U. ; CERN) ; Heinitz, Stephan (SCK-CEN, Mol) ; Heinke, Reinhard (Leuven U. ; CERN) ; Hurier, Sophie (Leuven U. ; SCK-CEN, Mol) et al.
$^{225}$Ac is a radio-isotope that can be linked to biological vector molecules to treat certain distributed cancers using targeted alpha therapy. However, developing $^{225}$Ac-labelled radiopharmaceuticals remains a challenge due to the supply shortage of pure $^{225}$Ac itself. [...]
2023 - 11 p.
- Published in : Sci. Rep. 13 (2023) 1347
Fulltext: PDF;
|
|
|
19.
|
|
Non-conventional radionuclides in personalised medicine
/ Stora, Thierry (speaker) (CERN)
Abstract:Nuclear Medicine, and more particularly the so-called theranostics approach based on the combination of diagnostics and treatment drugs, has seen recent breakthroughs, originating from radionuclides made newly available notably for European academic and industrial R&D scientists.A striking example is the use of targeted radiopharmaceuticals directed to the Prostate Specific Membrane Antigen (PSMA) and Somatostatin Receptor targeted therapy with 177Lu beta-emitter. Alpha-emitting radionuclides have also been applied successfully in research and clinic. [...]
2023 - 4326.
Academic Training Lecture Regular Programme, 2022-2023
External link: Event details
In : Non-conventional radionuclides in personalised medicine
|
|
|
20.
|
|